Navigation Links
Product Strategies for Non-Oral Hematology Drugs

DUBLIN, March 22, 2013 /PRNewswire/ --

Research and Markets has announced the addition of the "Product Strategies for Non-Oral Hematology Drugs" report to their offering.

The administration of non-oral drugs for the treatment of blood disorders has evolved over the past ten years to include heparin analogs and recombinant proteins designed to treat chronic conditions that are life threatening and often debilitating illnesses. As the availability of drugs based on new APIs or molecular entities has grown, the product strategies in the marketplace have increased in specificity and sophistication.

The chronic nature of many blood diseases and the growing trend toward patient self-administration for non-oral medications is requiring drug developers and product managers to refine their product strategy at the highest level, with formulation and device selection decisions being made prior to the clinical trial phase of development.

Key Topics Covered:

Executive Summary

Therapeutic Hematology Market Dynamics
- Evolution in Drug Therapies
- Growth of Self-Administration
- Key Markets for Hematology Drug Therapeutics
- Anemia
- Deep Vein Thrombosis
- Heart Valve Prosthesis
- Neutropenia
- Pulmonary Embolism
- Competitive Landscape
- Opportunities and Risks

Non-Oral Hematology Drug Formulation and Packaging Factors
- Extended Release Formulations
- Packaging - Vial vs Prefilled Device
- Vial Strategies
- Prefilled Device Strategies
- Prefilled Syringes
- Autoinjectors
- Pen Injectors

Non-Oral Hematology Drug Administration Factors
- Dosing
- Dose Frequency
- Route of Administration
- Intravenous
- Subcutaneous

Non-Oral Hematology Drugs - Product Analysis and Market Data

Profiles of Hematology Drug Companies

For more information, including full table of contents, please visit

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Research and Markets
Laura Wood , Senior Manager.
U.S. Fax: +1-646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals

SOURCE Research and Markets
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
2. Sensitech Inc. Products Receive Regulatory Compliance Approval from IATA
3. Haemonetics Signs Definitive Agreement to Acquire Pall Corporations Blood Collection, Filtration and Processing Product Lines For $551 Million
4. QIAGEN and Cardinal Health Collaborate to Offer Molecular Diagnostic Products to Smaller and Mid-sized U.S. Hospitals
5. Diabecline Antibiotic Receives Edison Award for Best New Pharmaceutical Product
6. China Biologic Products to Host Earnings Conference Call on May 9, 2012 at 8:00 a.m. EDT (NY)
7. National Stakeholders Meet To Consider Improvements In Antimicrobial Use In Food Animal Production
8. New Reproductive Support Dietary Supplement, Pregnitude™, Now Available For Women Having Difficulty Conceiving
9. China Biologic Products Reports Higher Results for the First Quarter 2012
10. Clinical Interest in BioElectronics Products Expands to the Wound Care Market
11. Allied Healthcare Products Reports Loss on Sales Decline
Post Your Comments:
(Date:11/27/2015)... 27, 2015 --> ... go online. The potential to save costs, improve treatment ... far from fully exploited as yet. Here, particular emphasis ... either via mobile tablet or directly at the patients, ... ) -->      (Photo: ...
(Date:11/27/2015)... , Nov. 26, 2015 ... addition of the "2016 Global Tumor ... Country Volume and Sales Segment Forecasts, Innovative ... report to their offering. --> ... of the "2016 Global Tumor Marker ...
(Date:11/26/2015)... 2015 --> ... blends immunotherapy with Bremachlorin-photodynamic therapy for advanced cancer. ... immunotherapy with Bremachlorin-photodynamic therapy for advanced cancer.   ... immunotherapy with Bremachlorin-photodynamic therapy for advanced cancer.   ... that immunotherapy can be efficiently combined with photodynamic therapy ...
Breaking Medicine Technology:
(Date:11/27/2015)... , ... November 27, 2015 , ... CBD College ... of Allied Health Education Programs (CAAHEP) awarded accreditation to its Diagnostic Medical Sonography program. ... accredited colleges, as only one of twelve colleges and universities in the state of ...
(Date:11/27/2015)... ... , ... Avid collector, Andrew Hawley from Vintage Rock Posters, announces his search ... one of Joplin's most famous and beautiful concert posters. The concert was held on ... Arbor. The According to Hawley, "It is hard to believe that Joplin's stardom was ...
(Date:11/26/2015)... Las Vegas, NV (PRWEB) , ... November 26, 2015 , ... ... holiday shopping strategy. Many customers choose to buy during the Black Friday and ... holiday gifts. Shoppers don’t need to search the Internet high and low to find ...
(Date:11/26/2015)... ... November 26, 2015 , ... The Catalent Applied Drug Delivery ... to integrate dose form selection in early phase drug development. The first of ... and bringing together the UK’s emerging life sciences companies, corporate partners, and investors, ...
(Date:11/26/2015)... ... 26, 2015 , ... WorldCare International, Inc., the first company ... Employee Benefits Conference. The Employee Benefits Conference was hosted by the International Foundation ... 11th, 2015. The conference was held at the Hawaii Convention Center in Honolulu, ...
Breaking Medicine News(10 mins):